Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill r...(functional potency declined with age lea...)
Navigation Links
Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers
Date:1/15/2008
functional potency declined with age, leaving potential autoimmune responses in the pancreas unchecked.
It is likely, the researchers say, that certain genetic predispositions, coupled with the possible contribution of external environmental factors or infections, could potentially alter regulatory T-cell function in susceptible individuals and trigger a full-scale diabetic autoimmune reaction in the pancreas.
Once they start, these immune responses are like a fire that goes unchecked by firemen, or a car going downhill without brakes, said Dr. Piccirillo. Moreover, he said, this discovery not only elucidates the mechanism by which type 1 diabetes is triggered, but it also points the way to the development of new immune system-based therapies for a whole range of diseases.
We believe that these regulatory cells may represent a kind of master switch, and by understanding how they are made, how they function and how they survive, we may be able to stop disease from occurring.
'/>"/>
| Contact: Mark Shainblum mark.shainblum@mcgill.ca 514-398-2189 McGill University Source:Eurekalert |
Related biology news :
1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Gender, coupled with diabetes, affects vascular disease development
3. Breakthrough research identifies how cells from pigs may cure diabetes
4. Botched production of insulin molecule may lead to diabetes
5. Joslin researchers uncover potential role of leptin in diabetes
6. Insulins brain impact links drugs and diabetes
7. Exercise improves thinking, reduces diabetes risk in overweight children
8. UVa Health System team uncovers genes role in type 1 diabetes
9. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
10. JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research
11. Cancer and arthritis therapy may be promising treatment for diabetes
Post Your Comments:
(Date:9/4/2008)...ze the tuna population? Can we compute how to tran...roduction? , Those and other questions will be t...ans, economists, biologists and environmental scie...stitute for Computational Sustainability, being la...Science Foundation (NSF). This program is designed...
(Date:9/4/2008)...pt. 4, 2008) A variety of organismsfrom bacteria...ythms, where the timing and duration of fundamenta...low them to adapt and survive, even under fluctuat...gnificant advances have been made to understand th...anslate into modifications in cellular physiology ...
(Date:9/4/2008)... Breast Cancer Symposium features the latest cutti...clinical breast cancer research. This year,s meeti...ches, as well as strides being made in diagnosing ... the best advantage of the symposium,s scientific ... to visit www.sabcs.org to view the new press po...
(Date:9/3/2008)...) The tumor suppressor gene pRb2/p130 may provide...es of soft tissue sarcoma (STS), according to an i...ng scientists at the Sbarro Institute for Cancer R...cience and Technology at Temple University in Phil...d Oncology, University of Siena and the Center of ...
Breaking Biology News(10 mins):Cornell gets $10 million NSF grant to establish new sustainability institute 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2International team reveals first prognosticator of survival in aggressive cancer 2American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals Inc 9194 1Boston Scientific Announces Court Decision 9189 1Boston Scientific Announces Court Decision 9189 2Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 1159 1Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 1159 2Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 1159 3Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 1159 4Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 1159 5More sun exposure may be good for some people 9188 1More sun exposure may be good for some people 9188 2More sun exposure may be good for some people 9188 3[0] Cornell gets $10 million NSF grant to establish new sustainability institute[1] Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource[0] 31st Annual San Antonio Breast Cancer Symposium[1] International team reveals first prognosticator of survival in aggressive cancer
... (MBL) has published the results of an EPA-funded ...t, when combined, the pollutants,bromoform, chloro...,known as BCE--can act synergistically to alter a ...entists have previously studied the effects,of the... anyone has,demonstrated that BCE,s components can...
... (MBL) has published the results of an EPA-funded ...t, when combined, the pollutants,bromoform, chloro...,known as BCE--can act synergistically to alter a ...entists have previously studied the effects,of the... anyone has,demonstrated that BCE,s components can...
...essfully prevented allergic reactions in laborator...University of California, Los Angeles (UCLA) resea...e, available online now. In the future, the invest... a new therapy not only for human cat allergies, b... those to peanuts. , The National Institute of All...
... of the prestigious scientific journal Proceedings... national academy of science) shows that the trans...d salmon populations is much larger and more exten... analysis of parasite transfer is a scientific mil... isolate and measure the impact of a fish farm on ...
Other Biology News:Study identifies predictors of HIV drug resistance in patients beginning triple therapy 2Study identifies predictors of HIV drug resistance in patients beginning triple therapy 3Clam embryo study shows pollutant mixture adversely affects nerve cell development 2Clam embryo study shows pollutant mixture adversely affects nerve cell development 3Novel Therapy Tested in Mice Could Chase Away Cat Allergies 2Novel Therapy Tested in Mice Could Chase Away Cat Allergies 3Researchers reveal the infectious impact of salmon farms on wild salmon 2Researchers reveal the infectious impact of salmon farms on wild salmon 3Researchers reveal the infectious impact of salmon farms on wild salmon 4(Date:9/4/2008)...ua-- Genesis,Pharmaceutical...enesis" or,the "Company"), a leading pharmaceutica... announced that it completed a 40-for-1 reverse st...ding under the symbol "GNPH.", Upon today,s marke...,under the symbol "GTEC" and will begin trading on...
(Date:9/4/2008)...: MS, EDMONTON, Sept. 4 / ... in the treatment of multiple sclerosis (MS), toda...(FDA) of the United States,has granted fast track ...e,(MBP8298), for the treatment of secondary progre... being evaluated in a U.S. pivotal phase III trial...
(Date:9/4/2008)...ntinue Efforts to Out-License Intellectual ... Sept. 4 /- Interleukin Gen...up International LLC, a division,of Alticor Inc., ...s to all,intellectual property related to genetic ...d Access Business Group under their research,agree...
(Date:9/3/2008)...uilding sustainable cities -- urban leaders and gl...on 21-22 Oct. 2008 for the landmark conference, Fu...ghts and solutions to urban developments and probl...orld-renowned futurist and authority on Einstein,s...keynote speaker, addressing how science and techno...
Breaking Biology Technology:Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 2Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 3BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 2BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 3BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 4Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests 2Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests 3Singapore to hold international 'pow-wow' 2Singapore to hold international 'pow-wow' 3[0] Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol[0] BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA[0] Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests[0] Singapore to hold international 'pow-wow'
... legislation, each individual law represents a com.... In the case of energy and electricity, one needs...d regulated utilities for providing electricity. E...ed-cost investments, for each unit of electricity ... and 13.9% per annum. Like any other business, the...
...your choice! , ,So what does government have to ...mean government -- I meant governance ! The...d governance. You could say that government caused...T governance. The considerable number of scandals ...ve reduced the publics trust in business. In 2002,...
...money isn,t the only solution to overcoming the ch...the genes and warm support received from parents a...cognitive and behavioral problems for which povert... the May issue of the journal Child Development. ,...ing childhood elevates a person,s risk of developi...
...om 2003 , , MADISON, Wis. -- Forty-five Wisconsi...004 Technology Awards Banquet for receiving over $...rants. The awards, held in conjunction with the W...recognize small business technology transfer (STTR...dvanced technology program (ATP) awards doled to W...
Other Biology Technology:U.S. manufacturing benefits if utilities can assist them with energy efficiency efforts 2U.S. manufacturing benefits if utilities can assist them with energy efficiency efforts 3U.S. manufacturing benefits if utilities can assist them with energy efficiency efforts 4Part 4 Project Performance Get on the path to continuous improvement 2Part 4 Project Performance Get on the path to continuous improvement 3Study shows that genes can protect kids against poverty 2Study shows that genes can protect kids against poverty 3Wisconsin technology companies awarded over $24 million in government funding 2Wisconsin technology companies awarded over $24 million in government funding 3Wisconsin technology companies awarded over $24 million in government funding 4CodeLink Activated Slides from GE Healthcare, formerly Amersham Biosciences
SYBR Gold nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms.
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to
Biology Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |